Correction to: Isoform-selective phosphoinositide 3-kinase inhibition ameliorates a broad range of fragile X syndrome-associated deficits in a mouse model

Christina Gross; Anwesha Banerjee; Durgesh Tiwari; Francesco Longo; Angela R. White; A. G. Allen; Lindsay M. Schroeder-Carter; Joseph C. Krzeski; Nada A. Elsayed; Rosemary Puckett; Eric Klann; Ralph A. Rivero; Shannon L. Gourley; Gary J. Bassell

doi:10.1038/s41386-022-01345-x

Correction to: Isoform-selective phosphoinositide 3-kinase inhibition ameliorates a broad range of fragile X syndrome-associated deficits in a mouse model

Christina Gross, Anwesha Banerjee, Durgesh Tiwari, Francesco Longo, Angela R. White, A. G. Allen, Lindsay M. Schroeder-Carter, Joseph C. Krzeski, Nada A. Elsayed, Rosemary Puckett, Eric Klann, Ralph A. Rivero, Shannon L. Gourley, Gary J. Bassell

Neural Science

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	1733
Number of pages	1
Journal	Neuropsychopharmacology
Volume	47
Issue number	9
DOIs	https://doi.org/10.1038/s41386-022-01345-x
State	Published - Aug 2022

ASJC Scopus subject areas

Pharmacology
Psychiatry and Mental health

Access to Document

10.1038/s41386-022-01345-x

Cite this

Gross, C., Banerjee, A., Tiwari, D., Longo, F., White, A. R., Allen, A. G., Schroeder-Carter, L. M., Krzeski, J. C., Elsayed, N. A., Puckett, R., Klann, E., Rivero, R. A., Gourley, S. L., & Bassell, G. J. (2022). Correction to: Isoform-selective phosphoinositide 3-kinase inhibition ameliorates a broad range of fragile X syndrome-associated deficits in a mouse model. Neuropsychopharmacology, 47(9), 1733. https://doi.org/10.1038/s41386-022-01345-x

Gross, C, Banerjee, A, Tiwari, D, Longo, F, White, AR, Allen, AG, Schroeder-Carter, LM, Krzeski, JC, Elsayed, NA, Puckett, R, Klann, E, Rivero, RA, Gourley, SL & Bassell, GJ 2022, 'Correction to: Isoform-selective phosphoinositide 3-kinase inhibition ameliorates a broad range of fragile X syndrome-associated deficits in a mouse model', Neuropsychopharmacology, vol. 47, no. 9, pp. 1733. https://doi.org/10.1038/s41386-022-01345-x

@article{3f804153d7af43369735bdd7d6f6d7b2,

title = "Correction to: Isoform-selective phosphoinositide 3-kinase inhibition ameliorates a broad range of fragile X syndrome-associated deficits in a mouse model",

author = "Christina Gross and Anwesha Banerjee and Durgesh Tiwari and Francesco Longo and White, {Angela R.} and Allen, {A. G.} and Schroeder-Carter, {Lindsay M.} and Krzeski, {Joseph C.} and Elsayed, {Nada A.} and Rosemary Puckett and Eric Klann and Rivero, {Ralph A.} and Gourley, {Shannon L.} and Bassell, {Gary J.}",

year = "2022",

month = aug,

doi = "10.1038/s41386-022-01345-x",

language = "English (US)",

volume = "47",

pages = "1733",

journal = "Neuropsychopharmacology",

issn = "0893-133X",

publisher = "Nature Publishing Group",

number = "9",

}

TY - JOUR

T1 - Correction to

T2 - Isoform-selective phosphoinositide 3-kinase inhibition ameliorates a broad range of fragile X syndrome-associated deficits in a mouse model

AU - Gross, Christina

AU - Banerjee, Anwesha

AU - Tiwari, Durgesh

AU - Longo, Francesco

AU - White, Angela R.

AU - Allen, A. G.

AU - Schroeder-Carter, Lindsay M.

AU - Krzeski, Joseph C.

AU - Elsayed, Nada A.

AU - Puckett, Rosemary

AU - Klann, Eric

AU - Rivero, Ralph A.

AU - Gourley, Shannon L.

AU - Bassell, Gary J.

PY - 2022/8

Y1 - 2022/8

UR - http://www.scopus.com/inward/record.url?scp=85131807820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85131807820&partnerID=8YFLogxK

U2 - 10.1038/s41386-022-01345-x

DO - 10.1038/s41386-022-01345-x

M3 - Comment/debate

C2 - 35701551

AN - SCOPUS:85131807820

SN - 0893-133X

VL - 47

SP - 1733

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

IS - 9

ER -

Correction to: Isoform-selective phosphoinositide 3-kinase inhibition ameliorates a broad range of fragile X syndrome-associated deficits in a mouse model

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this